Efficacy of combined hypo-fractionated radiotherapy and anti-PD-1 monotherapy in difficult-to-treat advanced melanoma patients

Efficacy of combined hypo-fractionated radiotherapy and anti-PD-1 monotherapy in difficult-to-treat advanced melanoma patients

Information on the role of radiotherapy in anti-PD-1 monoclonal antibody-treated melanoma patients is limited. We report on a prospective cohort of advanced melanoma patients treated simultaneously with radiotherapy and anti-PD-1 therapy between 01/01/15 and 30/06/16. Tumor evaluations (RECIST 1.1)...

Full description

Bibliographic Details
Main Authors: Anissa Roger, Adeline Finet, Blandine Boru, Alain Beauchet, Jean-Jacques Mazeron, Yves Otzmeguine, Astrid Blom, Christine Longvert, Marie-Florence de Maleissye, Magali Fort, Elisa Funck-Brentano, Philippe Saiag
Format: Article
Language:English
Published: Taylor & Francis Group 2018-07-01
Series:OncoImmunology
Subjects:
abscopal effect
melanoma
immunotherapy
anti-pd-1 monoclonal antibody
radiotherapy
Online Access:http://dx.doi.org/10.1080/2162402X.2018.1442166

Internet

http://dx.doi.org/10.1080/2162402X.2018.1442166

Similar Items